步长制药：控股子公司签订技术服务合同 总金额1080万元

Core Viewpoint - The company has signed a technical service contract with WuXi AppTec for pharmacokinetics and toxicology testing, which will enhance its drug development capabilities and efficiency [1] Group 1: Contract Details - The total amount of the contract is 10.8 million yuan, including a 6% tax [1] - Payments will be made in installments as per the contract agreement [1] Group 2: Strategic Implications - This collaboration is expected to expand the company's drug research and development capacity [1] - It aims to reduce the time and cost associated with clinical trials, ensuring the smooth progress of projects [1]